tradingkey.logo
tradingkey.logo
Buscar

Catheter Precision Inc

VTAK
Añadir a la lista de seguimiento
0.790USD
-0.085-9.83%
Cierre 07/02, 13:00ETCotizaciones retrasadas 15 min
2.13MCap. mercado
PérdidaP/E TTM

Más Datos de Catheter Precision Inc Compañía

Catheter Precision, Inc. is a medical device company bringing solutions to market to improve the treatment of cardiac arrhythmias. The Company is focused on developing technology for electrophysiology (EP) procedures by collaborating with physicians and continuously advancing its products. The Company's two primary products are the View into Ventricular Onset System (VIVO System) and LockeT. The VIVO System is a non-invasive imaging system that offers three-dimensional (3D) cardiac mapping to help with localizing the sites of origin of idiopathic ventricular arrhythmias in patients with structurally normal hearts prior to EP procedures. Its product, LockeT, is a suture retention device indicated for wound healing by distributing suture tension over a larger area in the patient in conjunction with a figure of eight suture closure. Its product portfolio also includes the Amigo Remote Catheter System. It is developing technology for the treatment of acute decompensated heart failure.

Información de Catheter Precision Inc

Símbolo de cotizaciónVTAK
Nombre de la empresaCatheter Precision Inc
Fecha de salida a bolsaSep 27, 2018
Director ejecutivoJenkins (David A)
Número de empleados22
Tipo de seguridadOrdinary Share
Fin del año fiscalSep 27
Dirección1670 Highway 160 West
CiudadFORT MILL
Bolsa de valoresNASDAQ OMX – NASDAQ Basic Amex
PaísUnited States of America
Código postal29708
Teléfono19736912000
Sitio Webhttps://www.ramed.com/
Símbolo de cotizaciónVTAK
Fecha de salida a bolsaSep 27, 2018
Director ejecutivoJenkins (David A)

Ejecutivos de Catheter Precision Inc

Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--
Nombre
Nombre/Posición
Posición
Accionistas
Cambio
Mr. David Jenkins
Mr. David Jenkins
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
Executive Chairman of the Board, Chief Executive Officer, Chief Commercial Officer
48.49K
+54.05%
Mr. Martin J. Colombatto
Mr. Martin J. Colombatto
Independent Director
Independent Director
2.00
--
Mr. James J. Caruso
Mr. James J. Caruso
Independent Director
Independent Director
--
--
Mr. Tony Dacosta
Mr. Tony Dacosta
Investor Relations
Investor Relations
--
--
Mr. Philip J. Anderson
Mr. Philip J. Anderson
Chief Financial Officer, Secretary
Chief Financial Officer, Secretary
--
--
Mr. Andrew (Andy) Arno
Mr. Andrew (Andy) Arno
Independent Director
Independent Director
--
--

Preguntas frecuentes

¿Quiénes son los cinco principales accionistas de Catheter Precision Inc?

Los cinco principales accionistas de Catheter Precision Inc son: Mr. David Jenkins

¿Cuántas instituciones poseen acciones de Catheter Precision Inc (VTAK)?

A fecha de 2026Q1, 28 instituciones poseen acciones de Catheter Precision Inc, con un valor de mercado combinado de aproximadamente 304.48K, lo que representa el 11.31% del total de acciones. En comparación con el 2025Q4, el accionariado institucional ha aumentado en 230261.00.